Literature DB >> 1253168

Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor.

L M Franks, A W Carbonell, V J Hemmings, P N Riddle.   

Abstract

A tissue culture cell line was established from an alveologenic lung carcinoma from a C57BL/lcrf-at mouse. The cells can be maintained in a completely defined serum-free medium. Tumors derived from the tissue culture cells grown in serum-free or serum-supplemented medium give rise to lung metastases. The ultrastructure of the tissue culture cells in both media is similar to that of spontaneous or induced alveologenic mouse lung tumors.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1253168

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


  20 in total

1.  Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo.

Authors:  Anna-Mary Young; Kyra M Archibald; Laura A Tookman; Alexander Pool; Kate Dudek; Carolyn Jones; Sarah L Williams; Katrina J Pirlo; Anne E Willis; Michelle Lockley; Iain A McNeish
Journal:  Mol Ther       Date:  2012-06-26       Impact factor: 11.454

2.  FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion.

Authors:  Timothy G Whitsett; Shannon P Fortin Ensign; Harshil D Dhruv; Landon J Inge; Paul Kurywchak; Kerri K Wolf; Janine LoBello; Christopher B Kingsley; Jeffrey W Allen; Glen J Weiss; Nhan L Tran
Journal:  Clin Exp Metastasis       Date:  2014-04-08       Impact factor: 5.150

3.  Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses.

Authors:  Norman Woller; Engin Gürlevik; Bettina Fleischmann-Mundt; Anja Schumacher; Sarah Knocke; Arnold M Kloos; Michael Saborowski; Robert Geffers; Michael P Manns; Thomas C Wirth; Stefan Kubicka; Florian Kühnel
Journal:  Mol Ther       Date:  2015-06-26       Impact factor: 11.454

4.  Epigenetic control of the immune escape mechanisms in malignant carcinomas.

Authors:  A Francesca Setiadi; Muriel D David; Robyn P Seipp; Jennifer A Hartikainen; Rayshad Gopaul; Wilfred A Jefferies
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

5.  Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.

Authors:  Jeff W Kwak; Jennifer Laskowski; Howard Y Li; Maria V McSharry; Trisha R Sippel; Bonnie L Bullock; Amber M Johnson; Joanna M Poczobutt; Alexander J Neuwelt; Stephen P Malkoski; Mary C Weiser-Evans; John D Lambris; Eric T Clambey; Joshua M Thurman; Raphael A Nemenoff
Journal:  Cancer Res       Date:  2017-11-08       Impact factor: 12.701

6.  HEX: a novel homeobox gene expressed during haematopoiesis and conserved between mouse and human.

Authors:  F K Bedford; A Ashworth; T Enver; L M Wiedemann
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

Review 7.  Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Authors:  Joshua Del Papa; Ryan G Clarkin; Robin J Parks
Journal:  Cancer Gene Ther       Date:  2020-07-01       Impact factor: 5.987

8.  Altered regulation of MHC class I genes in different tumor cell lines is reflected by distinct sets of DNase I hypersensitive sites.

Authors:  U Maschek; W Pülm; G J Hämmerling
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

9.  Disruption of the keratin filament network during epithelial cell division.

Authors:  E B Lane; S L Goodman; L K Trejdosiewicz
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

10.  Induction of assembly of MHC class I heavy chains with beta 2microglobulin by interferon-gamma.

Authors:  D Klar; G J Hämmerling
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.